BC
Birchview Capital Portfolio holdings
AUM
$101M
This Quarter Return
+6.36%
1 Year Return
+34.62%
3 Year Return
+103.2%
5 Year Return
+107.72%
10 Year Return
+352.1%
AUM
$123M
AUM Growth
+$123M
(-4%)
Cap. Flow
-$4.26M
Cap. Flow
% of AUM
-3.48%
Top 10 Holdings %
Top 10 Hldgs %
68.23%
Holding
60
New
2
Increased
7
Reduced
2
Closed
1
Top Buys
| 1 |
DocGo
DCGO
|
$1.25M |
| 2 |
Coherus Oncology, Inc. Common Stock
CHRS
|
$382K |
| 3 |
Axsome Therapeutics
AXSM
|
$319K |
| 4 |
Acadia Pharmaceuticals
ACAD
|
$185K |
| 5 |
AXDX
Accelerate Diagnostics
AXDX
|
$99K |
Top Sells
| 1 |
IMGN
Immunogen Inc
IMGN
|
$5.57M |
| 2 |
Cytokinetics
CYTK
|
$1.05M |
| 3 |
Liquidia Corp
LQDA
|
$148K |
Sector Composition
| 1 | Healthcare | 94.27% |
| 2 | Energy | 5.73% |
| 3 | Consumer Staples | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Cabaletta Bio
CABA
$133M
| $171K | 0.14% |
10,000
| – | – |
|
52
Gossamer Bio
GOSS
$562M
| $163K | 0.13% |
138,176
| – | – |
|
53
Ventyx Biosciences
VTYX
$171M
| $158K | 0.13% |
28,800
| – | – |
|
|
54
Liquidia Corp
LQDA
$2.38B
| $148K | 0.12% |
10,000
-10,000
| -50% | -$148K |
|
|
TSVT
55
DELISTED
2seventy bio
TSVT
| $106K | 0.09% |
19,833
| – | – |
|
56
BioCryst Pharmaceuticals
BCRX
$1.74B
| $102K | 0.08% |
20,000
| – | – |
|
57
InflaRx
IFRX
$108M
| $77K | 0.06% |
50,000
| – | – |
|
58
CERo Therapeutics
CERO
$9.06M
| $39.8K | 0.03% |
+12,972
| New | +$39.8K |
|
|
YTEN
59
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
| $7.13K | 0.01% |
18,750
| – | – |
|
|
IMGN
60
DELISTED
Immunogen Inc
IMGN
| – | – |
-188,000
| Closed | -$5.57M |
|